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The neutron spectrum and the absorbed dose in a Complementary Metal Oxide Semiconductor, has been estimated using Monte Carlo
methods. Eventually a person with a pacemaker becomes an oncology patient that must be treated in a linear accelerator. Pacemaker has
integrated circuits as CMOS that are sensitive to intense and pulsed radiation fields. Above 7 MV therapeutic beam is contaminated with
photoneutrons that could damage the CMOS. Here, the neutron spectrum and the absorbed dose in a CMOS cell was calculated, also the
spectra were calculated in two point-like detectors in the room. Neutron spectrum in the CMOS cell shows a small peak between 0.1 to
1 MeV and a larger peak in the thermal region, joined by epithermal neutrons, same features were observed in the point-like detectors. The
absorbed dose in the CMOS was 1.522× 10−17 Gy per neutron emitted by the source.
Keywords: Pacemaker; CMOS; radiotherapy; neutrons; Monte Carlo.
El espectro y la dosis absorbida, debida a neutrones, por un Semiconductor de ´Oxido Meta´lico Complementario ha sido estimada utilizando
me´todos Monte Carlo. Eventualmente, una persona con marcapasos se convierte en un paciente oncolo´gico que debe ser tratado en un
acelerador lineal. El marcapasos contiene circuitos integrados como los CMOS que son sensibles a los campos de radiacio´n intensos y
pulsados. El haz terape´utico de un LINAC operando a voltajes mayores a 7 MV esta´ contaminado con fotoneutrones que pueden dan˜ar el
CMOS. En este trabajo se estimo´ el espectro de neutrones y la dosis absorbida por un CMOS; adema´s, se calcularon los espectros de neutrones
en dos detectores puntuales ubicados dentro de la sala. El espectro de neutrones en el CMOS tiene un pico entre 0.1 y 1 MeV y otro en
la regio´n de los te´rmicos, conectados mediante neutrones epite´rmicos. Estas mismas caracterı´sticas se observan en los otros detectores. La
dosis absorbida por el CMOS es 1.522× 10−17 Gy por cada neutro´n emitido por el te´rmino fuente.
Descriptores: Marcapasos, CMOS, radioterapia, neutrones, Monte Carlo
PACS: 87.19.Hh; 07.50.Ek; 87.56.-v; 14.20.Dh; 87.55.K-.
1. Introduction
Pacemakers are one of the most important innovations of the
past century, since their development in the 50’s and are be-
coming common in the general population. Basically, a pace-
maker has the capacity to sense heart function and augment
it as needed, it works by delivering a very short (< 1.0 ms),
low voltage (< 3.0 V) electrical current via an insulated pac-
ing lead to the heart muscle at a preprogrammed rate (with a
random access memory above than 512 MB) [1-3].
Electromagnetic interference, EMI, and ionizing radia-
tion can influence the pacemaker function, therefore, in pa-
tients with pacemaker EMI and radiation can affect the pace-
maker operation when patient requires radiotherapy treat-
ment [4-6]. The frequency of patients with pacemakers that
need radiation therapy is increasing and is far from rare [3,7].
Few papers about oncology patients with pacemakers
have been published and the available clinical practice guide-
lines for such patients are occasionally inconsistent, inex-
plicit and differ between radiation oncology centers [3-9].
However, monitoring the device operation during and after
radiation treatment sessions and a close survey of patient per-
formance are required in patient management [10].
Since early 70’ up to actual cardiac pacemakers use
complimentary-metal-oxide silicon, CMOS, devices [6] be-
cause have low power consumption, however have reduced
radiation resistance, 100 to 1000 Grays, due to a phenomenon
known as hole trapping [6,9].
The American Association of Physicists in Medicine re-
port task group 34 published recommendations for irradiation
of pacemaker patients [6]. It was reported failures in CMOS
in different studies where high instantaneous dose rates were
applied. In general is recognized that a transient interference
from pulsed radiation beams, as those from linear acceler-
ators could affect the pacemaker, however there is a need of
further studies when the pacemaker is kept inside the machine
collimated edge of the beam. Also the report put in discus-
sion an inhibition of the pacemaker during turn on/off of cer-
tain linear accelerators, but without dangerous consequences
for the patient [5,6]. Inhibition occurs when the pacemaker
fails to produce a pulse or when are changed the characteris-
tics of that pulse (pulse form, repetition frequency, and am-
plitude).
The AAPM consider that EMI is not dangerous due to
the improvements made in the new linacs and pacemakers
[3]; however, the radiation dose to patients has not been re-
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duced and consequential damages are still a concern. The
studies mentioned in the AAPM report include older pace-
maker types, based on old bipolar semiconductor devices and
the first generation of CMOS, but modern pacemakers use
new CMOS circuits that are different in their sensitivity to
radiation and the type of malfunction observed [5].
Despite the scientific and technological advances and the
research to treat cancer, radiotherapy with LINACs are the
technique most frequently used worldwide [11]. Besides
the therapeutic radiation the patient is exposed to a neutron
field that is produced in LINACs working above 8 MeV in
Bremsstrahlung mode. Photoneutrons are originated in (γ, n)
nuclear reactions occurring in materials in the LINAC’s head,
patient body and bunker’s walls that have the Giant Dipole
Resonance in their cross sections [12, 13]. It has been re-
ported that neutron dose received by the radiotherapy patient
treated with a LINAC is not negligible [14,15].
Since realized studies to identify the malfunction of com-
mercial pacemaker only took into account the absorbed dose
produced by photons in radiotherapy rooms and was not con-
sidered the effect produced by neutron LINACs the aim of
this study is to calculate the neutron spectrum in one CMOS
of a pacemaker during a radiotherapy treatment with a 18 MV
LINAC.
2. Materials and methods
Neutron adsorbed dose estimation was made using Monte
Carlo method using the MCNP 5 code [16]. A generic ra-
diotherapy room was used [17], here the wall thickness were
smaller than those in actual bunkers, but the wall that sepa-
rates the linac’s hall to the maze. It was assumed the case of
a prostate treatment; a 10×10 cm2 irradiation area was mod-
eled. The linac head was modeled as a 10 cm-radius tungsten
sphere with a conic aperture. In the center of head model was
located a point-like isotropic source term modeled with the
Tosi et al., equation [18]. Patient body was modeled as a reg-
ular parallepiped phantom made of Frigerio’s gel equivalent
tissue [19]. In Figure 1 is shown the patient and linac’s head
models. The CMOS circuit was simulated as a 2 Ø × 1 cm2
polystyrene cylinder.
FIGURE 1. Linac’s head, CMOS and phantom models.
FIGURE 2. Neutron spectra in the CMOS cell the external detec-
tors.
In the Monte Carlo calculations beside the neutron spec-
trum and dose in the pacemaker, two point-like detectors
were included, on near the pacemaker and another a 100 cm
from the prostate.
3. Results and discussion
In Figure 2 are shown the neutron spectra in the CMOS and
in the external detectors.
Neutron spectrum in the CMOS has a peak between 0.1
to 1 MeV, which is the maximum peak in the Tosi et al. equa-
tion shifted to lower energies. It also contains a large contri-
bution of thermal neutrons. These features are produced by
the neutron moderation in the phantom materials.
In the neutron spectra calculated outside the phantom
can be noticed that both have approximately the same shape,
however the total neutron fluence is smaller in the detector a
1 m from prostate in comparison to detector locate near the
pacemaker. This difference is attributed to the distance with
respect the isocentre that is the only zone exposed to neutron
beam.
Neutrons are scattered out the phantom, reaching both de-
tectors, those neutrons loose energy becoming epithermal and
thermal, this last group is increased by those neutrons that
are scattered into the room by the linac walls, phenomenon
known as room-return [20,21].
In table I is shown the total neutron fluence in the CMOS
cell and the point-like detectors located outside the phantom.
TABLE I. Total neutron fluence in CMOS and detectors
Site Total fluence per
neutron emitted by
the LINAC’s head
[n/cm2]
In CMOS 2.7326×10−5± 4.35%
At 1m from prostate 7.6912×10−6± 0.04%
Close the CMOS outside of phantom 12296×10−5± 0.30%
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The largest fluence is in the CMOS, the neutron fluence
in the detector near the CMOS receive more neutrons than
the detector located a 1 m from the prostate this is due to
the distance, however in the three locations the spectra have
the same shape. Considering that the photon scattering in an
18 MV LINAC is not important then the pacemaker could
fail probable due to the (n, p) reactions occurring in the rich-
H material that covers the CMOS circuits. Also the presence
of thermal neutrons could induce activation in the CMOS’
materials.
This can be explained due to the distance from CMOS
cell to isocenter is smaller than distance from detectors to
isocenter, or due to the size of CMOS cell because this cell
has an area and the detectors are only points. Other expla-
nation of the major flux in CMOS can be the influence of
CMOS, phantom or air materials.
With the neutron spectrum reaching the CMOS the ab-
sorbed dose was calculated being 1.5222×10−17± 8.10% Gy
per neutron emitted by the source term. Roughly the neutron
intensity in a LINAC is 1E(12) s−1, therefore the absorbed
dose rate can be as large as 15.22 µGy/s.
4. Conclusions
The neutron spectrum in the model of one pacemaker CMOS
has been calculated using Monte Carlo methods. The spec-
trum was also estimated in two locations around the patient
phantom.
The neutron spectrum that reach the CMOS shows a peak
between 0.1 to 1 MeV, this neutrons can produce (n, p) reac-
tions in the H-rich material that covers the CMOS sensitive
materials damaging the circuitry.
Neutron absorbed dose by the CMOS is
1.5222×10−17 Gy per neutron emitted by the source term.
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